Validation of electrochemiluminescence assays for highly sensitive and reproducible quantification of a-synuclein in cerebrospinal fluid

Niels Kruse, Omar Ali El-Agnaf, Brit Mollenhauer

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

α-Synuclein (aSyn), a putative cerebrospinal fluid biomarker, may support the diagnosis of neurodegenerative diseases. Previous studies led to conflicting results due to different preanalytical and analytical procedures. Standardized assays are required to allow for comparison of results from different laboratories. Materials & methods: We performed a side-by-side validation of a commercially available (Meso Scale Discovery, MD, USA) and a 'homebrew' assay for quantification of aSyn according to published guidelines. Results: The data showed high sensitivity and reproducibility for both assays. Preanalytical and analytical parameters did not affect the outcome of measurements. Conclusion: We conclude that both assays are very close in performance and suitable for research application of cerebrospinal fluid aSyn.

Original languageEnglish
Pages (from-to)621-630
Number of pages10
JournalBioanalysis
Volume9
Issue number8
DOIs
Publication statusPublished - 1 Apr 2017
Externally publishedYes

Fingerprint

Synucleins
Cerebrospinal fluid
Cerebrospinal Fluid
Assays
Neurodegenerative Diseases
Biomarkers
Guidelines
Neurodegenerative diseases
Research

Keywords

  • Assay
  • Electrochemiluminescence
  • Validation
  • α-synuclein

ASJC Scopus subject areas

  • Analytical Chemistry
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Clinical Biochemistry
  • Medical Laboratory Technology

Cite this

Validation of electrochemiluminescence assays for highly sensitive and reproducible quantification of a-synuclein in cerebrospinal fluid. / Kruse, Niels; Ali El-Agnaf, Omar; Mollenhauer, Brit.

In: Bioanalysis, Vol. 9, No. 8, 01.04.2017, p. 621-630.

Research output: Contribution to journalArticle

@article{2b94b125f7434608a0666eafbd524007,
title = "Validation of electrochemiluminescence assays for highly sensitive and reproducible quantification of a-synuclein in cerebrospinal fluid",
abstract = "α-Synuclein (aSyn), a putative cerebrospinal fluid biomarker, may support the diagnosis of neurodegenerative diseases. Previous studies led to conflicting results due to different preanalytical and analytical procedures. Standardized assays are required to allow for comparison of results from different laboratories. Materials & methods: We performed a side-by-side validation of a commercially available (Meso Scale Discovery, MD, USA) and a 'homebrew' assay for quantification of aSyn according to published guidelines. Results: The data showed high sensitivity and reproducibility for both assays. Preanalytical and analytical parameters did not affect the outcome of measurements. Conclusion: We conclude that both assays are very close in performance and suitable for research application of cerebrospinal fluid aSyn.",
keywords = "Assay, Electrochemiluminescence, Validation, α-synuclein",
author = "Niels Kruse and {Ali El-Agnaf}, Omar and Brit Mollenhauer",
year = "2017",
month = "4",
day = "1",
doi = "10.4155/bio-2017-0005",
language = "English",
volume = "9",
pages = "621--630",
journal = "Bioanalysis",
issn = "1757-6180",
publisher = "Future Science",
number = "8",

}

TY - JOUR

T1 - Validation of electrochemiluminescence assays for highly sensitive and reproducible quantification of a-synuclein in cerebrospinal fluid

AU - Kruse, Niels

AU - Ali El-Agnaf, Omar

AU - Mollenhauer, Brit

PY - 2017/4/1

Y1 - 2017/4/1

N2 - α-Synuclein (aSyn), a putative cerebrospinal fluid biomarker, may support the diagnosis of neurodegenerative diseases. Previous studies led to conflicting results due to different preanalytical and analytical procedures. Standardized assays are required to allow for comparison of results from different laboratories. Materials & methods: We performed a side-by-side validation of a commercially available (Meso Scale Discovery, MD, USA) and a 'homebrew' assay for quantification of aSyn according to published guidelines. Results: The data showed high sensitivity and reproducibility for both assays. Preanalytical and analytical parameters did not affect the outcome of measurements. Conclusion: We conclude that both assays are very close in performance and suitable for research application of cerebrospinal fluid aSyn.

AB - α-Synuclein (aSyn), a putative cerebrospinal fluid biomarker, may support the diagnosis of neurodegenerative diseases. Previous studies led to conflicting results due to different preanalytical and analytical procedures. Standardized assays are required to allow for comparison of results from different laboratories. Materials & methods: We performed a side-by-side validation of a commercially available (Meso Scale Discovery, MD, USA) and a 'homebrew' assay for quantification of aSyn according to published guidelines. Results: The data showed high sensitivity and reproducibility for both assays. Preanalytical and analytical parameters did not affect the outcome of measurements. Conclusion: We conclude that both assays are very close in performance and suitable for research application of cerebrospinal fluid aSyn.

KW - Assay

KW - Electrochemiluminescence

KW - Validation

KW - α-synuclein

UR - http://www.scopus.com/inward/record.url?scp=85019747508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019747508&partnerID=8YFLogxK

U2 - 10.4155/bio-2017-0005

DO - 10.4155/bio-2017-0005

M3 - Article

VL - 9

SP - 621

EP - 630

JO - Bioanalysis

JF - Bioanalysis

SN - 1757-6180

IS - 8

ER -